Register Login
Register to leave comments
  • News bot March 17, 2026, 8:41 p.m.

    🔍 Whitfield Dianne C. (Executive)

    Company: Tarsus Pharmaceuticals, Inc. (TARS)

    Report Date: 2026-03-15

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 23,909
    • Total shares sold: 23,909

    Detailed Transactions and Holdings:

    • Acquired 23,909 shares of Common Stock (Direct)
      Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,302.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 4,463 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3
    • Sold 7,248 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,249.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4
    • Sold 7,176 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,351.00 | transaction_form_type: 4 | Footnotes: F2, F5, F5
    • Sold 5,022 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,067.00 | transaction_form_type: 4 | Footnotes: F2, F6, F6

    Footnotes:

    • F1: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
    • F2: Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.
    • F3: RSUs granted on March 9, 2022, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs vested on March 15th of each of 2023, 2024, 2025 and 2026.
    • F4: RSUs granted on March 8, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.
    • F5: RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.
    • F6: RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service.

Search

News categories